Keywords: amgen, outlines, business, strategy, sustaining, growth, continued

Amgen Outlines Business Strategy For Sustaining Growth

Article | 25 November 1998

Print This

Continued strong sales of Epogen (epoetin alfa) and Neupogen(filgrastim) have given Amgen the opportunity to invest in the discovery ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in